Author

C. L. Murall

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Evolutionary Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 3 Research Focus:phylogenetics / evolution· 2 Organism:virus· 2 Approach:deep learning· 1 Research Focus:ecology & biodiversity· 1 Assay:metagenomics· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

A. Ignatieva· 1 shared B. J. Shapiro· 1 shared B. Jeffery· 1 shared D. S. Palmer· 1 shared I. Guthrie· 1 shared J. Kelleher· 1 shared K. Eaton· 1 shared M. Vos· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperEvolutionary Biology

A. Ignatieva

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A Pandemic-Scale Ancestral Recombination Graph for SARS-CoV-2

S. H. Zhan, Y. Wong, A. Ignatieva, K. Eaton, I. Guthrie, B. Jeffery, D. S. Palmer, C. L. Murall, S. Otto, J. Kelleher

The paper infers an Ancestral Recombination Graph for 2.48 million SARS-CoV-2 genomes to account for recombination, providing a more accurate representation of viral genealogy than traditional trees.

bioRxiv · Jun 8, 2023 · PreprintEvolutionary Biology

Does diversity beget diversity in microbiomes?

N. J. Madi, M. Vos, C. L. Murall, P. Legendre, B. J. Shapiro

The paper investigates how microbial diversity influences further diversity in different biomes, finding that positive feedback is strongest in low-diversity environments but plateaus in high-diversity ones.

bioRxiv · Nov 20, 2020Evolutionary Biology

Modelling the evolution of viral oncogenesis

C. L. Murall, S. Alizon

This study models how viral oncogenesis evolves by analyzing the trade-offs between oncogenic benefits and epidemiological costs in DNA oncoviruses.

bioRxiv · Jan 18, 2019Evolutionary Biology